|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to net income: | |||||
| Depreciation and amortization | |||||
| Amortization of share-based compensation | |||||
| Non-cash revenue adjustments | |||||
| Gain on extinguishment of debt | |||||
| Amortization of net discounts (premiums) | |||||
| Mortgages | |||||
| Notes Payable to Banks | |||||
| Amortization of deferred financing costs | |||||
| Foreign currency and unrealized derivative loss (gain), net | |||||
| Non-cash interest expense (income) | |||||
| Gain on sales of real estate | |||||
| Equity in earnings of unconsolidated entities | |||||
| Distributions on common equity from unconsolidated entities | |||||
| Provisions for impairment | |||||
| Deferred income taxes | |||||
| Change in assets and liabilities | |||||
| Accounts receivable and other assets | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Investment in real estate | |||||
| Improvements to real estate, including leasing costs | |||||
| Investment in unconsolidated entities | |||||
| Investment in loans and preferred equity | |||||
| Proceeds from sales of real estate | |||||
| Return of investment from unconsolidated entities | |||||
| Net proceeds from sale of unconsolidated entities | |||||
| Proceeds from note receivable | |||||
| Insurance proceeds received | |||||
| Non-refundable escrow deposits | |||||
| Net cash paid in merger | |||||
| Net cash acquired in merger | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Cash distributions to common stockholders | |||||
| Cash distributions to preferred stockholders | |||||
| Borrowings on revolving credit facilities and commercial paper programs | |||||
| Payments on revolving credit facilities and commercial paper programs | |||||
| Proceeds from term loan | |||||
| Principal payment on term loans | |||||
| Proceeds from notes payable issued | |||||
| Principal payment on notes payable | |||||
| Principal payments on mortgages payable | |||||
| Mortgages | |||||
| Total principal payments on mortgages payable | |||||
| Payments upon extinguishment of debt | |||||
| Proceeds from common stock offerings, net | |||||
| Proceeds from dividend reinvestment and stock purchase plan | |||||
| Redemption of preferred stock | |||||
| Distributions to noncontrolling interests | |||||
| Contributions from noncontrolling interests | |||||
| Net receipts on derivative settlements | |||||
| Debt issuance costs | |||||
| Net cash received from Orion Divestiture | |||||
| Other financing activities, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
Loading...